Metro IVF

What Metro IVF does

Metro IVF is a Malaysian fertility treatment provider that delivers reproductive medicine services — including IVF, IUI, and related andrology/gynaecology solutions — to men and women seeking to conceive. The company is part of Metro Healthcare Berhad and trades on Bursa Malaysia under the ticker MHCARE (KLSE:MHCARE). Founded in 1999 and headquartered in Klang within the Klang Valley, Metro IVF has operated continuously for over two decades as a specialty clinic group.

The business model is service-based: revenue is generated per fertility treatment cycle, with patients typically paying out-of-pocket or via limited insurance coverage for assisted reproductive technology in Malaysia. The company employs between 101 and 250 staff, reflecting a mid-sized clinical operation. Its public listing provides capital market access, though specific clinic count, pricing tiers, payer mix, and operational KPIs are not disclosed in the available source material.

Strategically, Metro IVF competes in a trust-driven specialty where clinical outcomes, embryology lab capability, and brand reputation drive patient acquisition. The provided financials indicate revenue recovery and growth post-2022, with 2025 revenue (in sen) of approximately MYR 124M, gross profit near MYR 47M, and EBITDA around MYR 25.6M. The website source was limited to a loader/verification page, restricting deeper extraction on product portfolio, technology stack, partnerships, and management team.

Name

Metro IVF

Website

https://metro.com.my

Company type

Private

Founded year

1999

Headcount range

101–250 employees

Short description

Metro IVF is a Malaysian fertility clinic founded in 1999, publicly listed on Bursa Malaysia (MHCARE), providing IVF and reproductive medicine services to men and women from its Klang headquarters.

Ownership category

akta.pro rank

Product category

Fertility Clinic Services

NAICS

Family Planning Centers (62141)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Reproductive Endocrinology & Infertility (Endocrine) (HLAKADAI), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Fertility treatment
• Assisted reproduction
• Reproductive health
• IVF services
• Fertility clinic

Headquarters

HQ city

Klang

HQ country

Malaysia

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Core offering

Metro IVF provides fertility treatment and reproductive health solutions for men and women. Operating since 1999, the company delivers in-vitro fertilization and related fertility services through its clinic in Klang, Malaysia.

Product overview

Metro IVF is a fertility and reproductive health clinic. The source data available (a site loading/verification page) does not contain specific product or service offering details, modules, or portfolio information. No named products, sub-products, or modules could be extracted from the provided source material.

Differentiator

Problem solved

Functional benefit

Products and services

• Fertility Treatment

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Broad incumbents

• Genea: Australia-based fertility clinic group and embryology lab operator. Directly comparable in IVF service offering and clinic-led care model, though operating at a different geographic scale.
• Monash IVF: Publicly listed Australian fertility group with multi-country operations. Comparable business model and service mix as a larger, publicly traded fertility specialist benchmark.

Regional players

• Virtus Fertility Centre: Singapore fertility clinic with regional patient reach. Comparable specialty focus on IVF and reproductive endocrinology serving Southeast Asian patients.
• Mahkota Medical Centre: Malaysian multi-specialty hospital in Melaka that offers IVF among a broader service portfolio. Overlaps with Metro IVF in fertility offerings but operates as a general hospital rather than a specialist.
• Raffles Fertility Centre: Singapore-based fertility center within the Raffles Medical Group. Competes with Metro IVF for cross-border fertility tourism and medical-travel patients in the region.

Direct peers

• Bourn Hall Fertility Centre: Established fertility clinic group with operations in the UK, UAE, and India. Compares to Metro IVF as a multi-site IVF specialist serving both domestic and medical-tourism patients.
• TMC Fertility: One of Malaysia's largest fertility networks with multiple IVF centers across the country. Comparable to Metro IVF in geography, IVF focus, and multi-site clinic model.
• KL Fertility Centre: Boutique fertility clinic in Kuala Lumpur providing IVF, ICSI, and reproductive medicine. Competes directly with Metro IVF for urban Malaysian patients.
• Sunfert International: Malaysian fertility clinic group operating multiple centers in the Klang Valley and southern Malaysia. Overlaps with Metro IVF on both-gender fertility services and clinic-based delivery.
• Alpha Fertility Centre: Malaysian fertility specialist offering IVF and reproductive endocrinology services. Directly competes for the same Malaysian patient base and cross-border fertility tourism.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metro IVF